FN3K is reported to be involved in deglycating the Nrf2 through phosphorylation of lysine, and arginine and enhancing Nrf2 activity in hepatocellular carcinoma, consequently protecting the cancer cells through antioxidant mechanisms [4]. The gene discussed is FN3K; the disease is cancer.